Mercer Global Advisors
LUNG icon

Mercer Global Advisors’s Pulmonx LUNG Stock Holding History

Mercer Global Advisors’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.7K Buy
61,332
+12,565
+26% +$17.3K ﹤0.01% 3466
2026
Q1 		$62.9K Buy
48,767
+7,502
+18% +$12.4K ﹤0.01% 3104
2025
Q4 		$91.2K Sell
41,265
-41,192
-50% -$77.4K ﹤0.01% 2734
2025
Q3 		$134K Buy
82,457
+362
+0.4% +$757 ﹤0.01% 2474
2025
Q2 		$213K Buy
82,095
+14
+0% +$55 ﹤0.01% 2052
2025
Q1 		$552K Buy
82,081
+11
+0% +$78 ﹤0.01% 1413
2024
Q4 		$557K Buy
+82,070
New +$540K ﹤0.01% 1392

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Mercer Global Advisors's LUNG Position: Q2 2026 in Review

Mercer Global Advisors increased its Pulmonx (LUNG) stake by 26% in Q2 2026, buying an estimated $17.3K and bringing the position to 61,332 shares worth $79.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3466.

Mercer Global Advisors first reported a position in LUNG in Q4 2024 and has held it in 7 quarters since. The position peaked at $557K in Q4 2024. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Mercer Global Advisors held 61,332 shares of Pulmonx worth $79.7K as of Q2 2026.
  • Mercer Global Advisors bought 12,565 Pulmonx shares in Q2 2026, an estimated $17.3K.
  • Pulmonx made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3466 holding.
  • Mercer Global Advisors first reported a position in Pulmonx in Q4 2024 and has held it in 7 quarters since.
  • Mercer Global Advisors's Pulmonx position peaked at $557K in Q4 2024.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.